A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
Crossref DOI link: https://doi.org/10.1186/s12885-016-2933-6
Published Online: 2016-11-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiang, Nai-Jung
Chao, Tsu-Yi
Hsieh, Ruey-Kuen
Wang, Cheng-Hsu
Wang, Yi-Wen
Yeh, C. Grace
Chen, Li-Tzong
License valid from 2016-11-21